Literature DB >> 4214783

Role of interferon in six cell lines persistently infected with rubella virus.

T L Stanwick, J V Hallum.   

Abstract

Presistent infections with rubella virus were established in baby hamster kidney, BSC-1, HeLa, RK-13, rabbit embryo chondrocyte, and Vero cell lines. All of the cultures except Vero continually produced rubella virus and interferon to which the virus was sensitive. Concurrently, only the Vero cells did not display interference against superinfection with Newcastle disease and vesicular stomatitis viruses. The addition of 1,000 U of exogenous interferon to the cultures cured only the rabbit embryo and Vero cells of the persistent infection. That the interferon is not required for the initiation and maintenance of rubella viral persistence in vitro is implied by the following. (1) Vero cells were persistently infected in the absence of interferon; (2) actinomycin D or cortisone inhibited interferon synthesis but not the rubella viral infection; and (3) cells continuously cultured in the presence of cortisone maintained a viral persistence without interferon synthesis. On the other hand, interferon seems to be responsible for the viral interference; Vero cells infected with rubella virus and cultures inoculated with rubella virus in the presence of actinomycin D or cortisone did not display interference against Newcastle disease or vesicular stomatitis viruses.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214783      PMCID: PMC423026          DOI: 10.1128/iai.10.4.810-815.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  ISOLATION OF RUBELLA VIRUS FROM CASES IN BRITAIN.

Authors:  K MCCARTHY; C H TAYLOR-ROBINSON; S E PILLINGER
Journal:  Lancet       Date:  1963-09-21       Impact factor: 79.321

2.  BIOLOGICAL CHARACTERISTICS OF RUBELLA VIRUS AS ASSAYED IN A HUMAN AMNION CULTURE SYSTEM.

Authors:  T H WELLER; F A NEVA
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  RNA-dependent DNA polymerase activity in preparations of a mutant of Newcastle disease virus arising from persistently infected L cells.

Authors:  P A Furman; J V Hallum
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

4.  Virus carrier cells and virus-free cells in fetal rubella.

Authors:  W E Rawls; J Desmyter; J L Melnick
Journal:  Proc Soc Exp Biol Med       Date:  1968-11

5.  Persistent rubella virus production in embryonic rabbit chondrocyte cell cultures.

Authors:  J L Smith; E M Early; W T London; D A Fuccillo; J L Sever
Journal:  Proc Soc Exp Biol Med       Date:  1973-09

6.  Interferon in congenital rubella: response to live attenuated measles vaccine.

Authors:  J Desmyter; W E Rawls; J L Melnick; M D Yow; F F Barrett
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

7.  Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture.

Authors:  A Vaheri; W D Sedwick; S A Plotkin; R Maes
Journal:  Virology       Date:  1965-10       Impact factor: 3.616

8.  Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero).

Authors:  J Desmyter; J L Melnick; W E Rawls
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

9.  Effect of exogenous interferon on rubella virus production in carrier cultures of cells defective in interferon production.

Authors:  K Mifune; J Desmyter; W E Rawls
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

10.  Rubella infection of synovial cells and the resistance of cells derived from patients with rheumatoid arthritis.

Authors:  A I Grayzel; C Beck
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

View more
  16 in total

1.  Persistent infection of L cells with vesicular stomatitis virus: evolution of virus populations.

Authors:  J S Youngner; O T Preble; E V Jones
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

2.  Effects of exogenous interferon on L cells persistently infected with Sendai virus.

Authors:  Y Ito; Y Nishiyama; K Shimokata; K Maeno
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

3.  Persistent reovirus infection of CHO cells resulting in virus resistance.

Authors:  R Taber; V Alexander; W Whitford
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

4.  Evaluating the Biological Role of Lassa Viral Z Protein-Mediated RIG-I Inhibition Using a Replication-Competent Trisegmented Pichinde Virus System in an Inducible RIG-IN Expression Cell Line.

Authors:  Da Di; Qinfeng Huang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2022-08-01       Impact factor: 6.549

5.  Analysis of gene expression in fetal and adult cells infected with rubella virus.

Authors:  Maria Pilar Adamo; Marta Zapata; Teryl K Frey
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

6.  The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses.

Authors:  Margaret R MacDonald; Erica S Machlin; Owen R Albin; David E Levy
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  Inducible viral receptor, A possible concept to induce viral protection in primitive immune animals.

Authors:  Tirasak Pasharawipas
Journal:  Virol J       Date:  2011-06-28       Impact factor: 4.099

8.  Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity.

Authors:  Sophiya Karki; Melody M H Li; John W Schoggins; Suyan Tian; Charles M Rice; Margaret R MacDonald
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

9.  Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells.

Authors:  Ludmila Perelygina; Adebola Adebayo; Maureen Metcalfe; Joseph Icenogle
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Persistent infection of human fetal endothelial cells with rubella virus.

Authors:  Ludmila Perelygina; Qi Zheng; Maureen Metcalfe; Joseph Icenogle
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.